Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Chen, Yen Ta ^a   Sun, Cheuk Kwan ^a,b   Lin, Yu Chun ^a   Chang, Li Teh ^c   Chen, Yung Lung ^a   Tsai, Tzu Hsien ^a   Chung, Sheng Ying ^a   Chua, Sarah ^a   Kao, Ying Hsien ^b   Yen, Chia Hong ^d   Shao, Pei Lin ^e   Chang, Kuan Cheng ^f   Leu, Steve ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CREATININE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; VON WILLEBRAND FACTOR; ANTIOXIDANT;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; THERAPY EFFECT; UREA NITROGEN BLOOD LEVEL; ANIMAL; APOPTOSIS; BLOOD; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KIDNEY TUBULE; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; URINE;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD31; ANTIOXIDANTS; APOPTOSIS; BLOOD UREA NITROGEN; CREATININE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY; KIDNEY TUBULES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; VON WILLEBRAND FACTOR;

EID: 79955550171     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-51     Document Type: Article

References (29)

1. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008, 168:987-995. 10.1001/archinte.168.9.987, 18474763.
2. Friedericksen DV, Van der Merwe L, Hattingh TL, Nel DG, Moosa MR. Acute renal failure in the medical ICU still predictive of high mortality. S Afr Med J 2009, 99:873-875.
3. Sementilli A, Franco M. Renal acute cellular rejection: correlation between the immunophenotype and cytokine expression of the inflammatory cells in acute glomerulitis, arterial intimitis, and tubulointerstitial nephritis. Transplant Proc 2010, 42:1671-1676. 10.1016/j.transproceed.2009.11.042, 20620497.
4. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996, 334:1448-1460. 10.1056/NEJM199605303342207, 8618585.
5. Zuk A, Bonventre JV, Brown D, Matlin KS. Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney. Am J Physiol 1998, 275:C711-731.
6. da Silva LB, Palma PV, Cury PM, Bueno V. Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury. Int Immunopharmacol 2007, 7:1609-1616. 10.1016/j.intimp.2007.08.014, 17996670.
7. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation 121:2211-2220. 10.1161/CIRCULATIONAHA.109.928796, 2919223, 20458011.
8. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006, 17:1135-1142. 10.1681/ASN.2005060668, 16495381.
9. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18:1292-1298. 10.1681/ASN.2006070756, 17314324.
10. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007, 292:F1626-1635. 10.1152/ajprenal.00339.2006, 17213465.
11. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007, 18:2486-2496. 10.1681/ASN.2007020140, 17656474.
12. Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, Lee FY, Sun CK. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 2008, 72:1336-1345. 10.1253/circj.72.1336, 18654023.
13. Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R, Nagler A, Reisner Y. Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 2006, 24:1185-1193. 10.1634/stemcells.2005-0265, 16410390.
14. Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007, 18:2921-2928. 10.1681/ASN.2006121318, 17942965.
15. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 2005, 68:1613-1617. 10.1111/j.1523-1755.2005.00573.x, 16164638.
16. Leu S, Lin YC, Yuen CM, Yen CH, Kao YH, Sun CK, Yip HK. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010, 8:63. 10.1186/1479-5876-8-63, 2913939, 20584315.
17. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008, 26:2705-2712. 10.1634/stemcells.2008-0034, 18535155.
18. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001, 72:1625-1631. 10.1097/00007890-200111270-00008, 11726821.
19. Sun CK, Zhang XY, Sheard PW, Mabuchi A, Wheatley AM. Change in mitochondrial membrane potential is the key mechanism in early warm hepatic ischemia-reperfusion injury. Microvasc Res 2005, 70:102-110. 10.1016/j.mvr.2005.04.003, 15893342.
20. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009, 37:1197-1205. 10.1097/CCM.0b013e31819c0667, 19242323.
21. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005, 289:F31-42. 10.1152/ajprenal.00007.2005, 15713913.
22. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 2002, 110:1083-1091. 150794, 12393844.
23. Behr L, Hekmati M, Fromont G, Borenstein N, Noel LH, Lelievre-Pegorier M, Laborde K. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Nephron Physiol 2007, 107:p65-76. 10.1159/000109821, 17940346.
24. Bussolati B, Tetta C, Camussi G. Contribution of stem cells to kidney repair. Am J Nephrol 2008, 28:813-822. 10.1159/000137681, 18535367.
25. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 2010, 1:2. 10.1186/scrt2, 2873698, 20504283.
26. Maines MD, Raju VS, Panahian N. Spin trap (N-t-butyl-alpha-phenylnitrone)-mediated suprainduction of heme oxygenase-1 in kidney ischemia/reperfusion model: role of the oxygenase in protection against oxidative injury. J Pharmacol Exp Ther 1999, 291:911-919.
27. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, Baty CJ, Karlsson JM, Watkins SC, Kim HP, Wang X, et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 2007, 36:409-417. 10.1165/rcmb.2006-0214OC, 1899328, 17079780.
28. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, Plotkin M, Goligorsky MS. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 2008, 74:879-889. 10.1038/ki.2008.304, 2782525, 18596729.
29. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation 2010, 121:2211-2220. 10.1161/CIRCULATIONAHA.109.928796, 2919223, 20458011.